These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35186051)

  • 21. Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders.
    Doan NT; Kaufmann T; Bettella F; Jørgensen KN; Brandt CL; Moberget T; Alnæs D; Douaud G; Duff E; Djurovic S; Melle I; Ueland T; Agartz I; Andreassen OA; Westlye LT
    Neuroimage Clin; 2017; 15():719-731. PubMed ID: 28702349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying Leukoaraiosis with Mild Cognitive Impairment by Fusing Multiple MRI Morphological Metrics and Ensemble Machine Learning.
    Yang Y; Hu Y; Chen Y; Gu W; Nie S
    J Imaging Inform Med; 2024 Apr; 37(2):666-678. PubMed ID: 38343235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of magnetic resonance imaging on the gray matter and resting-state function in prodromal and first-episode schizophrenia.
    Lian N; Lv H; Guo W; Shen Y; Wu R; Liu Y; Zhu F; Hu M; Ou J; Zhao J
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):537-545. PubMed ID: 30105860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Machine-Learning-Based Prediction Method for Hypertension Outcomes Based on Medical Data.
    Chang W; Liu Y; Xiao Y; Yuan X; Xu X; Zhang S; Zhou S
    Diagnostics (Basel); 2019 Nov; 9(4):. PubMed ID: 31703364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis.
    Sengupta SM; MacDonald K; Fathalli F; Yim A; Lepage M; Iyer S; Malla A; Joober R
    Schizophr Res; 2017 Jun; 184():116-121. PubMed ID: 27916287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Brain Atlases and Machine Learning Methods on the Discrimination of Schizophrenia Patients: A Multimodal MRI Study.
    Zang J; Huang Y; Kong L; Lei B; Ke P; Li H; Zhou J; Xiong D; Li G; Chen J; Li X; Xiang Z; Ning Y; Wu F; Wu K
    Front Neurosci; 2021; 15():697168. PubMed ID: 34385901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in Midline Gliomas.
    Kandemirli SG; Kocak B; Naganawa S; Ozturk K; Yip SSF; Chopra S; Rivetti L; Aldine AS; Jones K; Cayci Z; Moritani T; Sato TS
    World Neurosurg; 2021 Jul; 151():e78-e85. PubMed ID: 33819703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.
    Li Y; Zhang L; Zhang Y; Wen H; Huang J; Shen Y; Li H
    Neuropsychiatr Dis Treat; 2021; 17():847-857. PubMed ID: 33776440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement.
    Zhang X; Zhang Y; Liao J; Jiang S; Yan J; Yue W; Zhang D; Yan H
    Neurosci Bull; 2018 Oct; 34(5):816-826. PubMed ID: 29779085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.
    Tang Y; Yang CM; Su S; Wang WJ; Fan LP; Shu J
    BMC Cancer; 2021 Nov; 21(1):1268. PubMed ID: 34819043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function.
    Chen J; Zang Z; Braun U; Schwarz K; Harneit A; Kremer T; Ma R; Schweiger J; Moessnang C; Geiger L; Cao H; Degenhardt F; Nöthen MM; Tost H; Meyer-Lindenberg A; Schwarz E
    JAMA Psychiatry; 2020 Jun; 77(6):628-636. PubMed ID: 32049268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
    Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
    JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting response to electroconvulsive therapy combined with antipsychotics in schizophrenia using multi-parametric magnetic resonance imaging.
    Gong J; Cui LB; Xi YB; Zhao YS; Yang XJ; Xu ZL; Sun JB; Liu P; Jia J; Li P; Yin H; Qin W
    Schizophr Res; 2020 Feb; 216():262-271. PubMed ID: 31826827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polygenic Risk Score for Schizophrenia and Face-Processing Network in Young Adulthood.
    Lieslehto J; Kiviniemi VJ; Nordström T; Barnett JH; Murray GK; Jones PB; Paus T; Veijola J
    Schizophr Bull; 2019 Jun; 45(4):835-845. PubMed ID: 30281090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine Learning Prediction of Treatment Outcome in Late-Life Depression.
    Grzenda A; Speier W; Siddarth P; Pant A; Krause-Sorio B; Narr K; Lavretsky H
    Front Psychiatry; 2021; 12():738494. PubMed ID: 34744829
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls.
    Holland JF; Cosgrove D; Whitton L; Harold D; Corvin A; Gill M; Mothersill DO; Morris DW; Donohoe G
    Am J Med Genet B Neuropsychiatr Genet; 2020 Dec; 183(8):445-453. PubMed ID: 32918526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort.
    Santoro ML; Ota V; de Jong S; Noto C; Spindola LM; Talarico F; Gouvea E; Lee SH; Moretti P; Curtis C; Patel H; Newhouse S; Carvalho CM; Gadelha A; Cordeiro Q; Bressan RA; Belangero SI; Breen G
    Transl Psychiatry; 2018 Aug; 8(1):174. PubMed ID: 30171181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features.
    Zarogianni E; Storkey AJ; Johnstone EC; Owens DG; Lawrie SM
    Schizophr Res; 2017 Mar; 181():6-12. PubMed ID: 27613509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort.
    Fond G; Bulzacka E; Boucekine M; Schürhoff F; Berna F; Godin O; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():8-18. PubMed ID: 30552914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.